Peripheral versus central muscarinic effects on blood pressure, cardiac contractility, heart rate, and body temperature in the rat monitored by radiotelemetry

Pharmacology and Toxicology

Volumn 89, Issue 1, 2001, Pages 35-42

  Smith, Edward G ^a,c   Padnos, Beth ^b   Gordon, Christopher J ^b  

^a NORFOLK STATE UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHLORPYRIFOS; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; ORGANOPHOSPHATE INSECTICIDE; OXOTREMORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CORE TEMPERATURE; ENZYME ACTIVITY; EXPOSURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HYPERTENSION; HYPOTHERMIA; MALE; MONITORING; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; Q WAVE; RAT; TELEMETRY;

ANIMALIA;

EID: 0034922447     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.2001.890106.x     Document Type: Article

References (25)

1. Alabaster, C. T., S. B. Andrew, S. F. Campbell, P. Ellis, C. G. Henderson, D. A. Roberts, K. S. Ruddock, G. M. R. Sammuels, & M. H. Stefaniak: 2(1H)-Quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives. J. Med. Chem. 1988, 31, 2048-2056.
2. Anderson, N. H., A. M. Devlin, D. Graham, J. J. Morton, C. A. Hamilton, J. L. Reid, N. J. Schork & A. F. Dominiczak: Telemetry for cardiovascular monitoring in a pharmacological study. New approaches to data analysis. Hyper tens. 1999, 33, [part II], 248-255.
3. Ballantyne, B. & T. C. Marrs: Overview of the biological and clinical aspects of organophosphates and carbamates. In: Clinical and experimental toxicology of organophosphates and carbamates. Eds.: B. Ballantyne & T. C. Marrs. Oxford: Butterworth-Heinemann, 1992, 3-14.
4. Bataillard, A., F. Sannajust, D. Yoccoz, G. Blanchet, H. Sentenac-Roumanou & J. Sassard: Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacology & Toxicology 1990, 67, 27-35.
5. Bern, R. M. & M.. N. Levy: Regulation of body temperature. In: Physiology. Mosby Press, 1998, 244-245.
6. Brockway, B. P., P. A. Mills, J. T. Miller & S. A. Azar: A new method for continuous chronic measurement and recording of blood pressure, heart rate, and activity in the rat via radiotelemetry. Clin. Exp. Hypertens. 1991, A13, 885-895.
7. Buccafusco, J. J.: The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol Rev. 1996, 48, 179-211.
8. Bunag, R. D.: Facts and fallacies about measuring blood pressure in rats. Clin. Expr. Hypertens. Theory and Practice 1983, A5 (10), 1659-1681.
9. Cambridge, D. & M. W. Whiting: Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: responses to changes in cardiac loading and heart rate. Cardiovasc. Res. 1986, 20, 444-450.
10. Eldefrawi, A. T., D. Jett & M. E. Eldefrawi: Direct actions of organophosphorus anticholinesterases on muscarinic receptors. In: Organophosphorus compounds: Chemistry, fate, and effects. Eds.: J. E. Chambers, P. E. Levi. San Diego Academic Press, 1992, 257-270.
11. Genest, J., O. Kuchel, P. Hamet & M. Cantin: Hypertension, pathophysiology and treatment, 2nd Edition, McGraw-Hill, New York, 1983.
12. Gordon, C. J.: Thermoregulation in laboratory mammals and humans exposed to anticholinesterase agents. Neurotoxicol. Terat. 1994, 16, 427-453.
13. Gordon, C. J., T. Grantham & Y. Yang: Hypothermia and delayed fever in the male and female rat exposed to chlorpyrifos. Toxicology 1997, 118, 149-158.
14. Gordon, C. J. & T. A. Grantham: Effect of central and peripheral cholinergic antagonist on chlorpyriphos-induced changes in body temperature in the rat. Toxicology 1999, 142, 15-28.
15. Gordon, G. J. & B. K. Padnos: Prolonged elevation in blood pressure i the unrestrained rat exposed to chlorpyrifos. Toxicology, 2000, 146, 1-13.
16. Haidman, J. G., A. G. Gillman & L. E. Limbird: In: Goodman & Gilman's The pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York, 1996.
17. Jenden, D. J.: In: Methods of pharmacological testing. Ed.: A. Burger. Marcel Dekker, Inc., New York, 1967, 337-361.
18. Kaplan, M. N.: Essential hypertension: Pathogensis. In: Clinical hypertension, 4th ed. William & Wilkins, 1986, pp 56-145.
19. Richardson, R. J.: Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature. J. Toxicol Env. Health 1995, 44, 135-165.
20. Ringdahl, B. & D. J. Jenden: Pharmacological properties of oxotremorine and its analogs. Life Sci. 1983, 32, 2401-2413.
21. Saadeh, A. M., N. A. Farsakh & M. K. Al-Ali: Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 1997, 77, 461-464.
22. Taylor, P.: Anticholinesterase agents. In: Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed. Eds.: J. G. Hardman, A. G. Gilman, L. E. Limbird, McGraw-Hill, New York, 1996, 161-176.
23. Trippodo, N. C. & E. D. Frohlich: Similarities of genetic (spontaneous) hypertension, man and rat. Circ. Res. 1981, 48, 309-319.
24. Varagic, V. M., M. S. Prostran, S. Stepanovic, J. Savic & S. Vujnov: Transmitter interactions in the central cholinergic control of blood pressure regulation. Drug Metab. Interact. 1991, 9, 49-76.
25. Vargas, H. M. & H. E. Brezenoff: Suppression of hypertension during chronic reduction of brain acetylcholine in spontaneously hypertensive rats. Hypertension 1988, 6, 739-745.